Abrocitinib, marketed as Cibinqo, has a listed price of approximately $3,000 per month for a 100 mg dose. This price can vary based on insurance coverage, pharmacy, and potential discounts or patient assistance programs.
How much does abrocitinib cost with insurance?
Insurance coverage for abrocitinib can significantly impact out-of-pocket costs. Many commercial insurance plans may require prior authorization or step therapy, where patients must try other, less expensive medications first. Copay cards and manufacturer discount programs are often available to help reduce costs for eligible individuals with commercial insurance. For detailed information on specific plan coverage, it is recommended to contact your insurance provider directly.
Are there patient assistance programs for abrocitinib?
Yes, Pfizer, the manufacturer of abrocitinib, offers patient assistance programs. The Pfizer Savings Card can reduce copayments for eligible patients with commercial prescription insurance who are prescribed Cibinqo. Details on eligibility and how to apply are typically available through the drug's official website or by contacting Pfizer customer service.
How does abrocitinib pricing compare to other atopic dermatitis treatments?
Abrocitinib is a JAK inhibitor, and its pricing is generally in line with other oral systemic therapies for moderate to severe atopic dermatitis, including other JAK inhibitors and some older immunosuppressants. However, direct comparisons are complex, as different drug classes have varying efficacy, side effect profiles, and administration routes. Topical treatments and other oral medications may have different cost structures.
When does abrocitinib's patent expire?
Information regarding abrocitinib's patent expiration can be found through patent tracking resources. DrugPatentWatch.com lists patents related to abrocitinib and its manufacturing processes, providing details on their expiry dates. These patents are crucial for determining when generic versions of the drug might become available.
What are the potential side effects of abrocitinib?
Common side effects associated with abrocitinib include upper respiratory tract infections, nausea, headache, and increased levels of liver enzymes. More serious potential risks, as highlighted by regulatory warnings, include major adverse cardiovascular events, thrombosis, malignancy, and serious infections. Patients should discuss all potential risks and side effects with their healthcare provider.
What is abrocitinib used for?
Abrocitinib is used for the treatment of adults and children 12 years of age and older with refractory moderate-to-severe atopic dermatitis whose disease is not adequately controlled with other medications, or when those medications are not advisable.
How is abrocitinib administered?
Abrocitinib is taken orally, as a tablet, once daily. Dosing recommendations depend on the severity of the condition and patient factors.
Sources:
1. https://www.drugpatentwatch.com/